George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccrol Gp Regulatory News (ACRL)

Share Price Information for Accrol Gp (ACRL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 38.30
Bid: 38.30
Ask: 38.40
Change: 0.00 (0.00%)
Spread: 0.10 (0.261%)
Open: 38.50
High: 38.50
Low: 38.30
Prev. Close: 38.30
ACRL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Senior Management Change

10 Apr 2019 07:00

RNS Number : 6771V
Accrol Group Holdings PLC
10 April 2019
 

 

10 April 2019

 

Accrol Group Holdings plc

("Accrol" or the "Group")

 

Senior Management Change: Appointment of Group Finance Director

 

Accrol, the UK's leading independent tissue converter, is pleased to announce that John Pilkington has accepted the permanent role of Group Finance Director with immediate effect.

 

John joined the senior management team of Accrol in September 2018, as Group Financial Controller. Since then, he has gained a strong understanding of the business and its financials and has been closely involved in the latter stages of the turnaround process.

 

John qualified as a Chartered Accountant with KPMG and has nearly 20 years' experience as a senior finance executive, including over 10 years with Promethean World Limited (formerly Promethean World Plc), latterly as Group Financial Controller.

 

Hannah Argo, who was appointed Interim Chief Financial Officer whilst a search for a permanent replacement was undertaken, has completed her contract and leaves the Company today.

 

Dan Wright, Executive Chairman of Accrol, said: "We are delighted that John has accepted the role of permanent Group Finance Director. His knowledge and understanding of the Group, gained during an intense and difficult period for the Group, will allow him to hit the ground running. The Board has been thoroughly impressed with his contribution and commitment to the business over the last seven months and we look forward to working with him even more closely."

 

"On behalf of all the directors, I thank Hannah for stepping into the role of Interim CFO and for her work during this time."

The Board remains unchanged, comprising Dan Wright (Executive Chairman), Gareth Jenkins (Chief Executive Officer), Euan Hamilton (Non-Executive) and Simon Allport (Non-Executive).

 

For further information, please contact:

 

 

 

Accrol Group Holdings plc

 

Dan Wright, Executive Chairman

Tel: +44 (0) 1254 278 844

Gareth Jenkins, Chief Executive Officer

 

 

 

Zeus Capital Limited (Nominated Adviser & Broker) 

 

Dan Bate / Andrew Jones

Tel: +44 (0) 161 831 1512

Dominic King / John Goold

Tel: +44 (0) 203 829 5000

 

 

Belvedere Communications Limited

 

Cat Valentine (cvalentine@belvederepr.com)

Tel: +44 (0) 7715 769 078

Keeley Clarke (kclarke@belvederepr.com)

Tel: +44 (0) 7967 816 525

Llew Angus (langus@belvederpr.com)

Tel: +44 (0)7407 023 147

 

Notes to Editors

 

Accrol Group Holdings plc, based in Lancashire, is a leading tissue converter and supplier of toilet rolls, kitchen rolls and facial tissues, as well as other tissue products, to major discounters and grocery retailers throughout the UK. Accrol operates from three sites:

 

·

A manufacturing, storage and distribution facility in Blackburn;

·

A facial tissue plant, also in Blackburn; and

·

A manufacturing, storage and distribution facility in Leyland.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOALLFIRSDIAIIA
Date   Source Headline
18th Mar 20213:23 pmRNSTR-1
5th Mar 20217:11 amRNSImplementation of LTIP and PDMR dealing
14th Jan 20217:00 amRNSPDMR Dealings
12th Jan 20217:00 amRNSHalf Year Results
7th Jan 20217:00 amRNSOnline HY 21 Investor Presentation
17th Dec 20207:00 amRNSNotice of Half Year Results
15th Dec 20207:00 amRNSOnline Investor Presentation
14th Dec 202011:05 amRNSSecond Price Monitoring Extn
14th Dec 202011:00 amRNSPrice Monitoring Extension
14th Dec 20209:05 amRNSSecond Price Monitoring Extn
14th Dec 20209:00 amRNSPrice Monitoring Extension
11th Dec 20208:51 amRNSTR-1
2nd Dec 20207:00 amRNSAppointment of Chief Financial Officer
27th Nov 202012:48 pmRNSTR-1
26th Nov 20207:00 amRNSTR-1
25th Nov 20207:00 amRNSCompletion of Acquisition
24th Nov 20201:54 pmRNSTR-1
24th Nov 20201:44 pmRNSTR-1
24th Nov 202011:28 amRNSTR-1
24th Nov 202010:54 amRNSTR-1
24th Nov 20207:00 amRNSPDMR Dealing
23rd Nov 20208:00 amRNSAdmission of Shares & Total Voting Rights
20th Nov 202011:32 amRNSResult of General Meeting
20th Nov 20207:00 amRNSResult of Open Offer
6th Nov 202011:55 amRNSTR-1
4th Nov 20205:13 pmRNSPosting of Circular
3rd Nov 20207:00 amRNSConfirmation of Successful Placing
2nd Nov 20204:59 pmRNSAcquisition and Launch of ABB
2nd Nov 20207:00 amRNSCOVID-19 Business Update
27th Oct 20202:44 pmRNSResult of AGM
25th Sep 20208:00 amRNSNotice of AGM and Posting of Accounts
2nd Sep 20207:00 amRNSAudited Final Results
25th Aug 20207:00 amRNSNotice of Results and Online Investor Presentation
22nd May 202012:40 pmRNSTR-1
21st May 20202:25 pmRNSTR-1
6th May 20207:00 amRNSTrading Update
25th Mar 202010:19 amRNSTR-1
23rd Mar 202011:35 amRNSTR-1
17th Mar 20207:00 amRNSAppointment of Joint Broker
4th Mar 20207:00 amRNSTR-1
3rd Mar 20209:41 amRNSTR-1
29th Jan 20207:00 amRNSDirector's Dealing
21st Jan 20209:13 amRNSTR-1
20th Jan 20207:00 amRNSRegulatory investigation closed
15th Jan 20207:00 amRNSTR-1
14th Jan 20207:00 amRNSTR-1
7th Jan 20207:00 amRNSHalf Year Results
16th Dec 20197:00 amRNSTR-1
13th Nov 201912:11 pmRNSTR-1
22nd Oct 201911:30 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.